The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, yet its legacy within the broader industry now presents questions about potential gains. Generic versions are diminishing patent protection , causing concerns that investing in companies significantly dependent to Viagra's former position could be a speculative